MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk
Catheterization and Cardiovascular Interventions2014Vol. 84(4), pp. 581–590
Citations Over TimeTop 10% of 2014 papers
Abstract
Based on high risk MC studies and high risk MVS data predominantly from STS database, patients with severe MR who are at HSR can be effectively treated with MC or MVS. MC can be safely implanted in high risk patients with relatively low mortality and stroke risk.
Related Papers
- → Mechanism and Severity of Mitral Regurgitation by Transesophageal Echocardiography in Patients Referred for Percutaneous Valve Repair(2011)39 cited
- → Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunction(2021)26 cited
- → Transcatheter mitral valve edge-to-edge repair in patients with severe mitral regurgitation: data from the MitraClip Russia Trial(2022)8 cited
- → Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip(2020)5 cited
- → Impact of etiology of mitral regurgitation (MR) on results after interventional mitral valve repair using the MitraClip system in high-surgical-risk patients(2012)